Analyze Diet
Journal of virology2026; 100(8); e0082826; doi: 10.1128/jvi.00828-26

Equine infectious anemia virus Mat protein serves as a Tat cofactor to facilitate viral transcription.

Abstract: Equine infectious anemia virus (EIAV) is a member of the genus of the family and serves as an important model for studying lentiviral pathogenesis. A novel EIAV-encoded protein, designated Mat, was previously identified in our laboratory, yet its biological functions remained unclear. Here, we demonstrate that disruption of Mat moderately reduced EIAV replication in equine monocyte-derived macrophages, and this defect was restored when Mat was supplied in . Further analyses revealed that Mat exhibits nuclear localization and enhances Tat-mediated transcriptional activation of the long terminal repeat (LTR), an essential and conserved step in lentiviral replication, by interacting with viral Tat and the host factor Cyclin T1 (CycT1), but not with the trans-acting responsive RNA element (TAR) within the LTR. Moreover, we found that Mat stabilizes EIAV Tat (eTat) and promotes the association of eTat with both TAR and equine CycT1. These findings indicate that Mat serves as a cofactor of Tat to regulate EIAV replication.IMPORTANCEIn lentiviruses, Tat-mediated activation of the LTR promoter is essential for viral replication. Mechanistically, Tat binds to TAR (a structured RNA at the 5' end of nascent viral transcripts, corresponding to the R region of the LTR), recruits host factors, including CycT1, and facilitates RNA polymerase II elongation, thereby promoting efficient production of full-length viral transcripts required for lentiviral replication. We recently identified an uncharacterized EIAV protein, Mat. Here, we show that Mat inactivation moderately attenuates EIAV replication , and this defect is rescued by ectopic Mat expression. Mat enhances Tat-mediated activation of EIAV LTR activity, and we further confirm that Mat interacts with EIAV Tat (eTat) and equine CycT1 (eqCycT1), stabilizes eTat, and promotes the association of eTat with both TAR and eqCycT1. These results suggest that Mat acts as an eTat cofactor in EIAV transcriptional regulation, providing insights into the complex transcriptional regulatory mechanisms of lentiviruses.
Publication Date: 2026-07-27 PubMed ID: 42505242PubMed Central: PMC13483383DOI: 10.1128/jvi.00828-26Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Overview

  • This study investigates the function of a novel protein called Mat in the equine infectious anemia virus (EIAV), showing that Mat acts as a cofactor for the viral protein Tat to enhance viral gene transcription and replication.

Background

  • Equine infectious anemia virus (EIAV) is a lentivirus, belonging to the Retroviridae family, which causes disease in horses and serves as a model for studying lentiviral pathogenesis.
  • Lentiviruses rely heavily on the Tat protein to activate transcription from the virus’s long terminal repeat (LTR) promoter, which is critical for viral replication.
  • Tat binds to a structured RNA element called TAR in the viral RNA and recruits host factors like Cyclin T1 to facilitate transcription elongation by RNA polymerase II.
  • Despite this well-known mechanism, other viral proteins and cofactors involved in regulating EIAV transcription were not fully understood before this study.

Identification and Role of Mat Protein

  • The researchers previously discovered an uncharacterized EIAV-encoded protein named Mat in their laboratory.
  • They found that inactivating or disrupting Mat moderately reduced EIAV replication in equine monocyte-derived macrophages, a primary cell type infected by EIAV.
  • This replication defect was restored when Mat was reintroduced, indicating its functional importance in virus replication.

Mat Protein Mechanism of Action

  • Subcellular localization studies showed that Mat is predominantly located in the nucleus, consistent with an involvement in viral gene transcription regulation.
  • Mat enhances the transcriptional activation capability of EIAV Tat on the viral LTR promoter, a critical step for effective viral replication.
  • Mat physically interacts with the viral Tat protein and the host cell factor Cyclin T1 (CycT1), which is necessary for Tat’s function.
  • Unlike Tat, Mat does not bind directly to the TAR RNA element of the LTR, suggesting it modulates transcription through protein-protein interactions rather than RNA binding.
  • Mat stabilizes the Tat protein (referred to as eTat in EIAV), preventing its degradation and thus enhancing its activity.
  • Mat promotes the formation of a complex between Tat, TAR, and equine Cyclin T1 (eqCycT1), facilitating efficient viral transcript elongation by RNA polymerase II.

Significance and Implications

  • This study identifies Mat as a novel cofactor of Tat that contributes to efficient transcriptional regulation in EIAV.
  • By stabilizing Tat and promoting its interaction with necessary host factors, Mat enhances viral gene expression and replication.
  • Understanding the role of Mat provides new insights into the complex regulatory network governing lentiviral transcription.
  • These findings may inform future research on lentiviral biology and potentially contribute to developing antiviral strategies targeting transcriptional regulation in related viruses such as HIV.

Cite This Article

APA
Zhang X, Ma W, Ma X, Guo X, Zhang W, Wang X-F, Wang X. (2026). Equine infectious anemia virus Mat protein serves as a Tat cofactor to facilitate viral transcription. J Virol, 100(8), e0082826. https://doi.org/10.1128/jvi.00828-26

Publication

ISSN: 1098-5514
NlmUniqueID: 0113724
Country: United States
Language: English
Volume: 100
Issue: 8
Pages: e0082826
PII: e00828-26

Researcher Affiliations

Zhang, Xiangmin
  • State Key Laboratory of Animal Disease Control and Prevention, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Harbin, China.
Ma, Weiwei
  • State Key Laboratory of Animal Disease Control and Prevention, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Harbin, China.
Ma, Xiaohua
  • State Key Laboratory of Animal Disease Control and Prevention, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Harbin, China.
Guo, Xing
  • State Key Laboratory of Animal Disease Control and Prevention, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Harbin, China.
Zhang, Weiguo
  • State Key Laboratory of Animal Disease Control and Prevention, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Harbin, China.
Wang, Xue-Feng
  • State Key Laboratory of Animal Disease Control and Prevention, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Harbin, China.
Wang, Xiaojun
  • State Key Laboratory of Animal Disease Control and Prevention, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Harbin, China.
  • Institute of Western Agriculture, Chinese Academy of Agricultural Sciences, Changji, China.
  • China-Kazakhstan Joint Laboratory for Herbivorous Animal Disease Research, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China.

MeSH Terms

  • Infectious Anemia Virus, Equine / genetics
  • Infectious Anemia Virus, Equine / physiology
  • Infectious Anemia Virus, Equine / metabolism
  • Animals
  • Horses
  • Gene Products, tat / metabolism
  • Gene Products, tat / genetics
  • Virus Replication
  • Viral Transcription
  • Gene Expression Regulation, Viral
  • Viral Proteins / metabolism
  • Viral Proteins / genetics
  • Macrophages / virology
  • Cyclin T / metabolism
  • Cyclin T / genetics
  • Terminal Repeat Sequences
  • Transcriptional Activation
  • RNA, Viral / genetics

Grant Funding

  • 32170169 / National Natural Science Foundation of China
  • 32172831 / National Natural Science Foundation of China

Conflict of Interest Statement

The authors declare no conflict of interest.

References

This article includes 44 references
  1. Cook RF, Leroux C, Issel CJ. Equine infectious anemia and equine infectious anemia virus in 2013: a review. Vet Microbiol 167:181–204.
    doi: 10.1016/j.vetmic.2013.09.031pubmed: 24183747google scholar: lookup
  2. Leroux C, Cadoré J-L, Montelaro RC. Equine infectious Anemia virus (EIAV): what has HIV’s country cousin got to tell us?. Vet Res 35:485–512.
    doi: 10.1051/vetres:2004020pubmed: 15236678google scholar: lookup
  3. Zhang B, Jin S, Jin J, Li F, Montelaro RC. A tumor necrosis factor receptor family protein serves as a cellular receptor for the macrophage-tropic equine lentivirus. Proc Natl Acad Sci USA 102:9918–9923.
    doi: 10.1073/pnas.0501560102pmc: PMC1174982pubmed: 15985554google scholar: lookup
  4. Schimmich C, Vabret A, Zientara S, Valle-Casuso JC. Equine infectious anemia virus cellular partners along the viral cycle. Viruses 17:5.
    doi: 10.3390/v17010005pmc: PMC11769393pubmed: 39861793google scholar: lookup
  5. Sedore SC, Byers SA, Biglione S, Price JP, Maury WJ, Price DH. Manipulation of P-TEFb control machinery by HIV: recruitment of P-TEFb from the large form by Tat and binding of HEXIM1 to TAR. Nucleic Acids Res 35:4347–4358.
    doi: 10.1093/nar/gkm443pmc: PMC1935001pubmed: 17576689google scholar: lookup
  6. Marciniak RA, Sharp PA. HIV-1 Tat protein promotes formation of more-processive elongation complexes. EMBO J 10:4189–4196.
  7. Marciniak RA, Calnan BJ, Frankel AD, Sharp PA. HIV-1 Tat protein trans-activates transcription. Cell 63:791–802.
    doi: 10.1016/0092-8674(90)90145-5pubmed: 2225077google scholar: lookup
  8. Sherman L, Gazit A, Yaniv A, Kawakami T, Dahlberg JE, Tronick SR. Localization of sequences responsible for trans-activation of the equine infectious anemia virus long terminal repeat. J Virol 62:120–126.
    doi: 10.1128/JVI.62.1.120-126.1988pmc: PMC250509pubmed: 2824840google scholar: lookup
  9. Cordingley MG, LaFemina RL, Callahan PL, Condra JH, Sardana VV, Graham DJ, Nguyen TM, LeGrow K, Gotlib L, Schlabach AJ. Sequence-specific interaction of Tat protein and Tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 87:8985–8989.
    doi: 10.1073/pnas.87.22.8985pmc: PMC55085pubmed: 2247474google scholar: lookup
  10. Wei P, Garber ME, Fang SM, Fischer WH, Jones KA. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92:451–462.
    doi: 10.1016/s0092-8674(00)80939-3pubmed: 9491887google scholar: lookup
  11. Zhu Y, Pe’ery T, Peng J, Ramanathan Y, Marshall N, Marshall T, Amendt B, Mathews MB, Price DH. Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation. Genes Dev 11:2622–2632.
    doi: 10.1101/gad.11.20.2622pmc: PMC316609pubmed: 9334325google scholar: lookup
  12. Garber ME, Wei P, KewalRamani VN, Mayall TP, Herrmann CH, Rice AP, Littman DR, Jones KA. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev 12:3512–3527.
    doi: 10.1101/gad.12.22.3512pmc: PMC317238pubmed: 9832504google scholar: lookup
  13. Taube R, Fujinaga K, Irwin D, Wimmer J, Geyer M, Peterlin BM. Interactions between equine cyclin T1, Tat, and TAR are disrupted by a leucine-to-valine substitution found in human cyclin T1. J Virol 74:892–898.
  14. Noiman S, Gazit A, Tori O, Sherman L, Miki T, Tronick SR, Yaniv A. Identification of sequences encoding the equine infectious anemia virus tat gene. Virology 176:280–288.
    doi: 10.1016/0042-6822(90)90254-opubmed: 2158694google scholar: lookup
  15. Willbold D, Krüger U, Frank R, Rosin-Arbesfeld R, Gazit A, Yaniv A, Rösch P. Sequence-specific resonance assignments of the 1H-NMR spectra of a synthetic, biologically active EIAV Tat protein. Biochemistry 32:8439–8445.
    doi: 10.1021/bi00084a008pubmed: 8395203google scholar: lookup
  16. Rosin-Arbesfeld R, Willbold D, Yaniv A, Gazit A. The Tat protein of equine infectious anemia virus (EIAV) activates cellular gene expression by read-through transcription. Gene 1998 219:25–35.
    doi: 10.1016/s0378-1119(98)00389-8pubmed: 9756988google scholar: lookup
  17. Albrecht TR, Lund LH, Garcia-Blanco MA. Canine cyclin T1 rescues equine infectious anemia virus tat trans-activation in human cells. Virology 2000 268:7–11.
    doi: 10.1006/viro.1999.0141pubmed: 10683321google scholar: lookup
  18. Anand K, Schulte A, Fujinaga K, Scheffzek K, Geyer M. Cyclin box structure of the P-TEFb subunit cyclin T1 derived from a fusion complex with EIAV tat. J Mol Biol 2007 370:826–836.
    doi: 10.1016/j.jmb.2007.04.077pmc: PMC1987359pubmed: 17540406google scholar: lookup
  19. Wang X-F, Zhang X, Ma W, Li J, Wang X. Host cell restriction factors of equine infectious anemia virus. Virol Sin 2023 38:485–496.
    doi: 10.1016/j.virs.2023.07.001pmc: PMC10436108pubmed: 37419416google scholar: lookup
  20. Ali A, Mishra R, Kaur H, Chandra Banerjea A. HIV-1 Tat: an update on transcriptional and non-transcriptional functions. Biochimie 2021 190:24–35.
    doi: 10.1016/j.biochi.2021.07.001pubmed: 34242726google scholar: lookup
  21. Sawaya BE, Khalili K, Gordon J, Taube R, Amini S. Cooperative interaction between HIV-1 regulatory proteins Tat and Vpr modulates transcription of the viral genome. J Biol Chem 2000 275:35209–35214.
    doi: 10.1074/jbc.M005197200pubmed: 10931842google scholar: lookup
  22. Joseph AM, Ladha JS, Mojamdar M, Mitra D. Human immunodeficiency virus-1 Nef protein interacts with Tat and enhances HIV-1 gene expression. FEBS Lett 2003 548:37–42.
    doi: 10.1016/s0014-5793(03)00725-7pubmed: 12885404google scholar: lookup
  23. Hong H-W, Lee S-W, Myung H. Induced degradation of Tat by nucleocapsid (NC) via the proteasome pathway and its effect on HIV transcription. Viruses 2013 5:1143–1152.
    doi: 10.3390/v5041143pmc: PMC3705270pubmed: 23611845google scholar: lookup
  24. Lata S, Ali A, Sood V, Raja R, Banerjea AC. HIV-1 Rev downregulates Tat expression and viral replication via modulation of NAD(P)H:quinine oxidoreductase 1 (NQO1). Nat Commun 2015 6:7244.
    doi: 10.1038/ncomms8244pubmed: 26059226google scholar: lookup
  25. Zhang X, Li J, Zhang M, Bai B, Ma W, Lin Y, Guo X, Wang X-F, Wang X. A novel, fully spliced, accessory gene in equine lentivirus with distinct rev-responsive element. J Virol 2022 96.
    doi: 10.1128/jvi.00986-22pmc: PMC9517694pubmed: 36069548google scholar: lookup
  26. Li J, Zhang X, Bai B, Zhang M, Ma W, Lin Y, Wang X, Wang X-F. Identification of a novel post-transcriptional transactivator from the equine infectious Anemia virus. J Virol 2022 96.
    doi: 10.1128/jvi.01210-22pmc: PMC9769392pubmed: 36448796google scholar: lookup
  27. Liu J, Wang H, Huang C, Qian H. Subcellular localization of MTA proteins in normal and cancer cells. Cancer Metastasis Rev 2014 33:843–856.
    doi: 10.1007/s10555-014-9511-7pubmed: 25398252google scholar: lookup
  28. Bauer NC, Doetsch PW, Corbett AH. Mechanisms regulating protein localization. Traffic 2015 16:1039–1061.
    doi: 10.1111/tra.12310pubmed: 26172624google scholar: lookup
  29. Marcello A, Zoppé M, Giacca M. Multiple modes of transcriptional regulation by the HIV-1 Tat transactivator. IUBMB Life 2001 51:175–181.
    doi: 10.1080/152165401753544241pubmed: 11547919google scholar: lookup
  30. Freed EO. HIV-1 replication. Somat Cell Mol Genet 2001 26:13–33.
    doi: 10.1023/a:1021070512287pubmed: 12465460google scholar: lookup
  31. Rausch JW, Le Grice SFJ. HIV rev assembly on the rev response element (RRE): a structural perspective. Viruses 7:3053–3075.
    doi: 10.3390/v7062760pmc: PMC4488727pubmed: 26075509google scholar: lookup
  32. Carpenter S, Dobbs D. Molecular and biological characterization of equine infectious anemia virus Rev. Curr HIV Res 8:87–93.
    doi: 10.2174/157016210790416424pubmed: 20210784google scholar: lookup
  33. Ali A, Banerjea AC. Curcumin inhibits HIV-1 by promoting Tat protein degradation. Sci Rep 6:27539.
    doi: 10.1038/srep27539pmc: PMC4901322pubmed: 27283735google scholar: lookup
  34. Bai B, Zhang X, Zhang M, Ma W, Li J, Zhang H, Na L, Guo X, Lin Y, Wang X-F, Wang X. EIAV encodes an accessory protein that antagonizes the host restriction factor equine tetherin. Proc Natl Acad Sci USA 122:e2413703122.
    doi: 10.1073/pnas.2413703122pmc: PMC12232724pubmed: 40549908google scholar: lookup
  35. Kmiec D, Kirchhoff F. Antiviral factors and their counteraction by HIV-1: many uncovered and more to be discovered. J Mol Cell Biol 16:mjae005.
    doi: 10.1093/jmcb/mjae005pmc: PMC11334937pubmed: 38318650google scholar: lookup
  36. Li F, Puffer BA, Montelaro RC. The S2 gene of equine infectious anemia virus is dispensable for viral replication. J Virol 72:8344–8348.
  37. Wolf D, Witte V, Clark P, Blume K, Lichtenheld MG, Baur AS. HIV Nef enhances Tat-mediated viral transcription through a hnRNP-K-nucleated signaling complex. Cell Host Microbe 4:398–408.
    doi: 10.1016/j.chom.2008.08.013pubmed: 18854243google scholar: lookup
  38. Sugiyama R, Naganuma H, Nishitsuji H, Takaku H. Human immunodeficiency virus-1 Nef suppresses Hsp70-mediated Tat activation. FEBS Lett 585:3367–3371.
    doi: 10.1016/j.febslet.2011.09.029pubmed: 21970979google scholar: lookup
  39. Wang X-F, Bai B, Lin Y, Qi T, Du C, Song M, Wang X. High-efficiency rescue of equine infectious Anemia virus from a CMV-driven infectious clone. Virol Sin 34:725–728.
    doi: 10.1007/s12250-019-00153-wpmc: PMC6888787pubmed: 31376080google scholar: lookup
  40. Wang XF, Liu Q, Wang YH, Chen J, Lin YZ. Characterization of equine infectious Anemia virus long terminal repeat quasispecies and. J Virol .
    doi: 10.1128/jvi.02150-17pmc: PMC5874411pubmed: 29386282google scholar: lookup
  41. Wang X-F, Wang Y-H, Bai B, Zhang M, Chen J, Zhang X, Gao M, Wang X. Truncation of the cytoplasmic tail of equine infectious Anemia virus increases virion production by improving env cleavage and plasma membrane localization. J Virol 95:e0108721.
    doi: 10.1128/JVI.01087-21pmc: PMC8577380pubmed: 34495693google scholar: lookup
  42. Hu Z, Chang H, Ge M, Lin Y, Wang X, Guo W, Wang X. Development of antigen capture ELISA for the quantification of EIAV p26 protein. Appl Microbiol Biotechnol 98:9073–9081.
    doi: 10.1007/s00253-014-6078-8pubmed: 25256618google scholar: lookup
  43. Liu Q, Ma J, Wang X-F, Xiao F, Li L-J, Zhang J-E, Lin Y-Z, Du C, He X-J, Wang X, Zhou J-H. Infection with equine infectious anemia virus vaccine strain EIAVDLV121 causes no visible histopathological lesions in target organs in association with restricted viral replication and unique cytokine response. Vet Immunol Immunopathol 170:30–40.
  44. Tang Y-D, Na L, Zhu C-H, Shen N, Yang F, Fu X-Q, Wang Y-H, Fu L-H, Wang J-Y, Lin Y-Z, Wang X-F, Wang X, Zhou J-H, Li C-Y. Equine viperin restricts equine infectious anemia virus replication by inhibiting the production and/or release of viral Gag, Env, and receptor via distortion of the endoplasmic reticulum. J Virol 88:12296–12310.
    doi: 10.1128/JVI.01379-14pmc: PMC4248950pubmed: 25122784google scholar: lookup

Citations

This article has been cited 0 times.